Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Invasive Breast Lobular Carcinoma”

159 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 159 results

Large-scale testing (Phase 3)UnknownNCT01126138
What this trial is testing

Capecitabine (NX) Versus Docetaxel Plus Capecitabine (TX) as 1-line Chemotherapy on Metastatic Breast Cancer (MBC)

Who this might be right for
Carcinoma, Invasive Ductal, Breast
Chinese Academy of Medical Sciences 200
Testing effectiveness (Phase 2)Active Not RecruitingNCT00295893
What this trial is testing

Combination Chemotherapy With or Without Trastuzumab in Treating Patients With Stage II or Stage III Breast Cancer

Who this might be right for
Breast Cancer
City of Hope Medical Center 121
Not applicableUnknownNCT01038258
What this trial is testing

Monitoring Response After The First Chemotherapy Cycle After Neoadjuvant Breast Cancer Therapy

Who this might be right for
Invasive Ductal CarcinomaLobular Breast CarcinomaInflammatory Breast Carcinoma
Auxilio Mutuo Cancer Center 80
Early research (Phase 1)Ended earlyNCT02876640
What this trial is testing

Retinoid 9cUAB30 in Producing a Biologic Effect in Patients With Early Stage Breast Cancer

Who this might be right for
Anatomic Stage I Breast Cancer AJCC v8Anatomic Stage IA Breast Cancer AJCC v8Anatomic Stage IB Breast Cancer AJCC v8+6 more
National Cancer Institute (NCI) 27
Testing effectiveness (Phase 2)Study completedNCT02199418
What this trial is testing

Addition of Cisplatin to Neoadjuvant Therapy for T Locally Advanced Breast Cancer

Who this might be right for
Tubular Breast CancerMucinous Breast CancerInvasive Ductal Breast Cancer+1 more
RenJi Hospital 132
Large-scale testing (Phase 3)Looking for participantsNCT03201861
What this trial is testing

Addition of Cisplatin to Adjuvant Chemotherapy for Early Stage Breast Cancer in High-Risk Women

Who this might be right for
Tubular Breast CancerMucinous Breast CancerInvasive Duct Carcinoma of Breast
RenJi Hospital 762
Large-scale testing (Phase 3)Active Not RecruitingNCT01272037
What this trial is testing

Tamoxifen Citrate, Letrozole, Anastrozole, or Exemestane With or Without Chemotherapy in Treating Patients With Invasive RxPONDER Breast Cancer

Who this might be right for
Breast Ductal Carcinoma In SituInvasive Breast CarcinomaMulticentric Breast Carcinoma+2 more
National Cancer Institute (NCI) 5,018
Testing effectiveness (Phase 2)Active Not RecruitingNCT05900986
What this trial is testing

LS301-IT in Partial Mastectomy and Sentinel Lymph Node Biopsy (SLNB) for DCIS or Stage I-II Primary Invasive Breast Cancer

Who this might be right for
Breast CancerDCISInvasive Duct Carcinoma of Breast
Integro Theranostics 100
Testing effectiveness (Phase 2)Active Not RecruitingNCT02834013
What this trial is testing

Nivolumab and Ipilimumab in Treating Patients With Rare Tumors

Who this might be right for
Acinar Cell CarcinomaAdenoid Cystic CarcinomaAdrenal Cortical Carcinoma+91 more
National Cancer Institute (NCI) 818
Not applicableStudy completedNCT04498611
What this trial is testing

Prediction of Upgrade to Invasive Cancer in Patients Diagnosed With Ductal Carcinoma in Situ by Percutaneous Core Needle Biopsy

Who this might be right for
Carcinoma, Ductal, BreastInvasive Breast CancerIMAGE
Seoul National University Hospital 113
Not applicableLooking for participantsNCT06666439
What this trial is testing

Longitudinal Tumor Burden Quantification Using Circulating Tumor DNA in Metastatic Lobular Breast Cancer

Who this might be right for
Metastatic Invasive Lobular Carcinoma (mILC)
Julia Foldi 20
Not applicableStudy completedNCT03437161
What this trial is testing

A Prospective Trial to Compare Deep Inspiratory Breath Hold (DIBH) With Prone Breast Irradiation

Who this might be right for
Breast Cancer
NYU Langone Health 40
Testing effectiveness (Phase 2)Study completedNCT00256217
What this trial is testing

Chemoprevention Trial - Anastrozole in Ductal Carcinoma In Situ (DCIS) in Postmenopausal Women

Who this might be right for
DCIS
Rita Sanghvi, Mehta 42
Not applicableStudy completedNCT00058058
What this trial is testing

Magnetic Resonance Imaging in Women Recently Diagnosed With Unilateral Breast Cancer

Who this might be right for
Breast CancerContralateral Breast Cancer
American College of Radiology Imaging Network 1,007
Not applicableStudy completedNCT00581750
What this trial is testing

Molecular Genetic Basis of Invasive Breast Cancer Risk Associated With Lobular Carcinoma in Situ

Who this might be right for
Breast CancerLobular CarcinomaInvasive Breast Cancer
Memorial Sloan Kettering Cancer Center 550
Not applicableStudy completedNCT01815476
What this trial is testing

The Prone Breast Radiation Therapy Trial

Who this might be right for
Ductal Carcinoma In SituInvasive Breast Cancer
Toronto Sunnybrook Regional Cancer Centre 378
Testing effectiveness (Phase 2)Looking for participantsNCT07229417
What this trial is testing

IvoLoC Trial: A Phase II Trial Evaluating the Efficacy of Ivonescimab in Metastatic Endocrine Refractory HR-positive HER2-negative or Triple Negative Invasive Lobular Carcinoma

Who this might be right for
Metastatic Endocrine RefractoryTriple Negative Invasive Lobular Carcinoma
M.D. Anderson Cancer Center 29
Early research (Phase 1)Study completedNCT00004074
What this trial is testing

Interleukin-12 and Trastuzumab in Treating Patients With Cancer That Has High Levels of HER2/Neu

Who this might be right for
Advanced Adult Primary Liver CancerAnaplastic Thyroid CancerBone Metastases+124 more
National Cancer Institute (NCI) 15
Early research (Phase 1)Study completedNCT04750473
What this trial is testing

Fluciclovine and PSMA PET/CT for the Classification and Improved Staging of Invasive Lobular Breast Cancer

Who this might be right for
Anatomic Stage IV Breast Cancer AJCC v8Invasive Breast Lobular CarcinomaMetastatic Breast Lobular Carcinoma+1 more
Emory University 20
Not applicableStudy completedNCT04022772
What this trial is testing

Effect of PACK Health Support Program on Patient Reported Outcomes in Patients With Breast Cancer

Who this might be right for
Breast CarcinomaBreast Ductal Carcinoma In SituInvasive Breast Carcinoma+1 more
M.D. Anderson Cancer Center 287
Load More Results